Demographics: Most common in men of African descent (tightly curled/coiled hair shafts).
Risk Factors:
Close shaving with multi-blade manual razors.
Shaving against the grain or pulling skin taut during shaving.
Occupational requirements for clean-shaven appearance (e.g., military, law enforcement, fire service).
Clinical Features
History:
Recurrent pruritic, painful bumps localized to the beard area within 24–48 hours of shaving.
Physical Examination:
Erythematous, firm, inflammatory papules and pustules in the shaving zone (beard, jawline, submandibular neck).
Visible ingrown hairs piercing interfollicular epidermis (extrafollicular penetration) or looping back into the follicle (transfollicular penetration).
Sparing of non-shaved facial areas (e.g., upper cheeks, forehead).
Diagnosis
Initial/Screening: Clinical diagnosis based on characteristic lesion distribution and relationship to shaving habits.
Diff by pustules centered directly on follicular ostia (not ingrown hairs); (+) bacterial culture; often resolves with topical/oral antistaphylococcal Abx.
Acne Vulgaris:
Diff by presence of comedones (blackheads/whiteheads); distribution extends beyond beard area (forehead, nose, chest, back).
Diff by location strictly on the occipital scalp and posterior neck; presents as firm, follicular papules coalescing into fibrotic/keloidal plaques.
Contact Dermatitis:
Diff by diffuse erythema, pruritus, and edema without discrete follicular-based hair impalement; temporal link to specific shaving creams or aftershaves.
Management
First-Line (Conservative):
Cessation of shaving (“beard holiday”) for 2–4 weeks to allow hair to grow beyond skin surface.
Shaving modification (if shaving cannot be avoided):
Switch to electric clippers (leave stubble ≥1–2 mm).
Use single-blade safety razors.
Shave strictly in the direction of hair growth (with the grain) without stretching skin.
Hydrate skin and soften hair with warm water and lubricating shaving gels prior to blade contact.
Second-Line (Pharmacotherapy):
Topical retinoids (e.g., tretinoin, adapalene) to prevent follicular hyperkeratosis.
Low-potency topical corticosteroids (e.g., hydrocortisone 1–2.5%) short-term for acute inflammation.
Topical Abx/antiseptics (e.g., topical clindamycin, benzoyl peroxide, or azelaic acid) to suppress secondary bacterial colonization and inflammation.
Oral Abx (e.g., doxycycline) for extensive inflammatory lesions refractory to topicals.
Refractory / Definitive:
Laser hair removal (e.g., long-pulsed Nd:YAG 1064 nm—safest and most effective for darker Fitzpatrick skin types IV–VI) to achieve permanent follicular reduction.
Complications
Post-inflammatory hyperpigmentation (PIH) (common and cosmetically distressing in darker skin phototypes).
Secondary bacterial infection (impetiginization/abscess formation via S. aureus).